BRUCELLA GREEN VAC S.L. 

We develop a new generation of brucella vaccines, being BGV1 our 1st product, addressed to sheep and goat (€2.7bn SAMs)

OWNER

IGNACIO GRILLO (See Profile)


Sector

Veterinary Health

Stage

Prototyping, preclinical

Country

Spain


Our vaccine BGV1 is safe for all animals, thus allowing mass vaccination, unlike the classical Rev-1

BGV1 solves or mnimizes the DIVA problem, unlike the classical Rev-1

BGV1 allows uncomplicated control & eradication programmes, unlike the classical Rev-1

BGV1 is cost-effective, reducing financial impact in Public Health

Status

Pending

IP Type

PCT

Time

Countries

Belgium
China
France
Germany
Italy
Netherlands
Russia
Spain
Switzerland
USA
United Kingdom

Coverage

The use of BGV1 strain as a medicament for the treatment and/or prevention of brucellosis

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: 5th of October

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2021 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar